Orbimed Capital's Samuel Isaly has stepped down from his role as director on the board of the Worldwide Healthcare trust, after the group hired an external law firm to investigate allegations that he harassed and demeaned women for years, claims which he denies.
On 8 December, the group announced Isaly had relinquished his duties as portfolio manager after the allegations came to light, while this morning it was revealed he is no longer a director on the trust. A statement on the stock exchange said: "The board announces that Samuel Isaly has ceased to be a director of the company with effect from 12 January." Five former employees have accused Isaly of "perpetuating a toxic culture of sexual harassment". The following statement was made on 8 December: "The board of Worldwide Healthcare Trust has been advised by the partners of OrbiMed Ca...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
